Skip to main content

CORRECTION article

Front. Immunol., 24 January 2025
Sec. Viral Immunology
This article is part of the Research Topic Viral Infections and the Placenta: Interrogating a Black Box View all articles

Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19

Mingquan Guo,&#x;Mingquan Guo1,2†Menglu Gao&#x;Menglu Gao1†Jing Gao&#x;Jing Gao3†Tengfei ZhangTengfei Zhang1Xin JinXin Jin1Jian FanJian Fan1Qianying WangQianying Wang1Xin LiXin Li1Jian Chen*Jian Chen4*Zhaoqin Zhu*Zhaoqin Zhu1*
  • 1Department of Laboratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China
  • 2Shanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China
  • 3Department of Clinical Laboratory, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
  • 4Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Corrigendum on
Identifying risk factors for secondary infection post-SARS-CoV-2 infection in patients with severe and critical COVID-19

By Guo M, Gao M, Gao J, Zhang T, Jin X, Fan J, Wang Q, Li X, Chen J and Zhu Z (2021) Front. Immunol. 12:715023. doi: 10.3389/fimmu.2021.715023

In the published article, there was an error in the Funding statement. The incorrect grant number for the funding received by the National Natural Science Foundation of China was listed. The correct Funding statement appears below.

“This work was supported by grants from the National Natural Science Foundation of China (NSFC, 82101847), the Emergency Project of Shanghai Science and Technology Commission (No. 20411950502), the Shanghai Sailing Program (No. 21YF1438800) and Project of Shanghai Public Health Clinical Center (No. KY-GW-2020-15).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, secondary infection, immune response, metagenomics, risk factors

Citation: Guo M, Gao M, Gao J, Zhang T, Jin X, Fan J, Wang Q, Li X, Chen J and Zhu Z (2025) Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19. Front. Immunol. 15:1548101. doi: 10.3389/fimmu.2024.1548101

Received: 19 December 2024; Accepted: 20 December 2024;
Published: 24 January 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Guo, Gao, Gao, Zhang, Jin, Fan, Wang, Li, Chen and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jian Chen, eXVmdWNoZW5qaWFuQDE2My5jb20=; Zhaoqin Zhu, emhhb3FpbnpodUAxNjMuY29t

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.